UPL Limited share price

NSE: UPL · ISIN INE628A01036

Key numbers

Market cap
₹ 46,495 Cr
Current price
₹ 550.05
52-week high / low
₹ 812 / 544
Stock P/E
22.5
Book value
₹ 411.0
Dividend yield
1.09%
ROCE
10.4%
ROE
5.5%
Debt to equity
0.68
Sales growth (3 yrs)
-1.2%
Profit growth (3 yrs)
-18.6%
1-year return
-18.6%

About UPL Limited

UPL Limited, together with its subsidiaries, manufactures and sells pesticides, insecticides, and micronutrients in India, Brazil, the United States, the United Kingdom, and internationally. It operates through Crop protection, Seeds & Post-Harvest solutions, and Non-Agro segments. The company offers herbicides, fungicides, insecticides, acaricides, seed treatment, adjuvants, bio-solutions, public health products, fumigants, soil and water technologies, agrochemical products, and other agricultural related products under the Winger, Preview, Propose, and Nuvita brand names, as well as ProNutiva, a solution for crop protection. It also provides seeds for vegetables and crops, such as grain sorghum, forage, corn, canola, sunflower, rice, and wheat as well as other crops, including pearl millets, biofumingants, oats, mustards, and alfalfas under the Advanta, Alta Seeds, and Pacific Seeds brand names. In addition, the company offers industrial and specialty chemicals, such as phosphorus, cynation, phosgenation, and acrolein; other non-agricultural related products; post-harvest solutions; farmer education and engagement; environmental solutions; and apiculture services, as well as…

Quarterly results

Consolidated figures in ₹ crores

Mar 2025Jun 2025Dec 2025Mar 2026Jun 2026
Sales15,5739,21612,26918,33510,181
Operating profit3,2571,4952,4984,0261,606
Net profit896-883961,06110
EPS (₹)11.20-1.944.6912.570.12

Investor presentation summary (2026-08-03)

AI summary of the presentation · tone: Positive · source document

Key numbers

  • EBITDA Margin (%) 14.1% 14.7% +60 bps
  • EBITDA Margin (%) 6.5% 8.4% 190 bps

Guidance & outlook

  • IV PBT (₹109 cr) | (₹190 cr) Q1FY26 IV NWC Days(1)
  • Particulars (₹ cr) Q1FY26 Q1FY27 Change YoY

Growth & demand

  • significant volume growth in Advanta and specialty chemicals segment
  • Spechem vol. growth (+17% vs LY), lower AI vol. (phasing led)

Margins & costs

  • claims, changes in exchange and interest rates, changes in tax rates, raw materials and employee costs, our ability to identify and
  • Contribution margin EBITDA margin

Capex & expansion

  • complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or
  • El Niño impact on planting delays across major regions (e.g., India, Europe)

Peers in Agricultural Inputs

Data for information only, not investment advice. Prices end of day.